Preprint · OA
via OpenAlex
GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions
Pratap Meera, Mikko Uusi‐Oukari, Lipshutz Gerald S., Wallner Martin
UTUPub (University of Turku) · 2025
Abstract
Dementia and autoimmune diseases are prevalent conditions with limited treatment options. Taurine and homotaurine (HT) are naturally occurring sulfonate amino acids, with taurine being highly abundant in animal tissues, but declining with age in the blood. HT is a blood-brain barrier permeable drug under investigation for Alzheimer's disease. HT also has beneficial effects in a mouse model of multiple sclerosis likely through an anti-inflammatory mechanism mediated by GABAA receptor (GABAAR) agonism in immune cells. While both taurine and HT are structural GABA analogs and thought to be GABA mimetics at GABAARs, there is uncertainty concerning their potency as GABA mimetics on native GABAARs. We show that HT is a very potent GABA mimetic, as it evokes GABAAR-mediated currents with an EC50 of 0.4 μM (vs. 3.7 μM for GABA and 116 µM for taurine) in murine cerebellar granule cells in brain slices, with both taurine and HT having similar efficacy in activating native GABAARs. Furthermore, HT displaces the high affinity GABAAR ligand [3H]muscimol at similarly low concentrations (HT IC50 of 0.16 μM vs. 125 μM for taurine) in mouse brain homogenates. The potency of taurine and HT as GABAAR agonists aligns with endogenous concentrations of taurine in the blood and with HT concentrations achieved in the brain following oral administration of HT or the HT pro-drug ALZ-801. Consequently, we discuss that GABAARs subtypes, similar to the ones we studied here in neurons, are plausible targets for mediating the potential beneficial effects of taurine in health and life-span extension and the beneficial HT effects in dementia and autoimmune conditions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Meera, P., Uusi‐Oukari, M., S., L.G., & Martin, W. (2025). GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions. <em>UTUPub (University of Turku)</em>. https://openalex.org/W7137544274
Vancouver
Meera P, Uusi‐Oukari M, S. LG, Martin W. GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions. UTUPub (University of Turku). 2025.
BibTeX
@unpublished{pratap2025GABAAr,
title = {GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions},
author = {Pratap Meera and Mikko Uusi‐Oukari and Lipshutz Gerald S. and Wallner Martin},
journal = {UTUPub (University of Turku)},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2023
Open access · CC-BY
GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions
Amino Acids 2013
Open access · OA
Clinical significance of taurine
Boston University 2017
Open access · US-GOV
Feasibility of Using Physical Activity Monitoring for Enhancing Cognition in Healthy Seniors
Clinical and Translational Medicine 2022
Open access · CC-BY
Chaperonin‐containing TCP‐1 subunit 2‐mediated aggrephagy: A potential target for treating neurodegeneration
medRxiv 2025
Preprint · CC-BY
Associations of weight change and different obesity indices with all-cause and cause-specific mortality: the mediating role of epigenetic aging
AIDS 2018
Preprint · OA